FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4318833445> ?p ?o ?g. }

• W4318833445 endingPage "1378" @default.
• W4318833445 startingPage "1378" @default.
• W4318833445 abstract "According to the WHO, the secondary form of hematopoietic-depressive status increases the risk of death in people with oncological, infectious, and hormonal diseases. The choice of drugs that stimulate the hematopoietic activity of B-lymphopoiesis is limited. The current leucopoiesis drugs have a number of side effects: thymic preparations stimulate the production of PGE2, which causes chronic inflammation and various autoimmune diseases through the differentiation of T helper 1 (Th1) cells, the proliferation of Th17 cells, and the production of IL-22 from Th22 cells through EP2 and EP4 receptors; cytokine preparations can cause uncontrolled immune reactions and impaired contractility of smooth and cardiac muscles; drugs based on nucleic acids can stimulate the division of all cells, including bacterial and cancerous ones. The use of oligonucleotides such as ribozymes and antisense oligodeoxynucleotides (AS-ODNs) shows promise as therapeutic moieties, but faces a number of challenges such as nuclease sensitivity, off-target effects, and efficient delivery. The search for substances that stimulate B-lymphopoiesis among ionic compounds was motivated by the discovery of the unique properties of lidocaine docusate, one of the first ionic liquid forms of the known drugs. The lidocaine docusate (protonated form of lidocaine (2-(diethylamino)-N-(2,6-dimethylphenyl) acetamide + docusate-anion (dioctylsulfosuccinate))) suppresses the division of pheochromocytoma cells and activates immunity in rats. The trimecaine-based ionic compound (TIC) demonstrates high B-lymphopoiesis-stimulating activity. The TIC compound stimulates an increase in the volume of transitional B cells, which play an important role for further differentiation and formation of a sufficient number of mature B1 cells and mature B2 cells, where mature B2 cells make up the bulk of the functional population of B lymphocytes. The TIC compound most strongly stimulated the restoration of the number of marginal zone B cells, follicular B cells, and activated germinal center B cells after the cytotoxic emptying of the follicular centers of the spleen induced cyclophosphamide. It significantly exceeds the activity of the comparison drug methyluracil. The TIC compound does not affect the level of pro-B, pre-B-I, or pre-B-II bone marrow cells, which prevents the risk of the formation of immature functionally defective cells." @default.
• W4318833445 created "2023-02-02" @default.
• W4318833445 creator A5003434108 @default.
• W4318833445 creator A5016805219 @default.
• W4318833445 creator A5026687725 @default.
• W4318833445 creator A5035499808 @default.
• W4318833445 creator A5037603558 @default.
• W4318833445 creator A5039743320 @default.
• W4318833445 creator A5040901130 @default.
• W4318833445 creator A5051858730 @default.
• W4318833445 creator A5068356184 @default.
• W4318833445 creator A5070902222 @default.
• W4318833445 creator A5080365151 @default.
• W4318833445 creator A5084808804 @default.
• W4318833445 date "2023-02-01" @default.
• W4318833445 modified "2023-09-27" @default.
• W4318833445 title "Stimulation of B-Lymphopoiesis by Administration of a Trimecaine-Based Ionic Compound in Cyclophosphamide-Induced Hematopoietic-Depressive Model" @default.
• W4318833445 cites W1495046742 @default.
• W4318833445 cites W152786914 @default.
• W4318833445 cites W1560955538 @default.
• W4318833445 cites W1946552810 @default.
• W4318833445 cites W1974606314 @default.
• W4318833445 cites W1984607875 @default.
• W4318833445 cites W2001165391 @default.
• W4318833445 cites W2033441782 @default.
• W4318833445 cites W2036263584 @default.
• W4318833445 cites W2051340593 @default.
• W4318833445 cites W2063781602 @default.
• W4318833445 cites W2072186231 @default.
• W4318833445 cites W2075796333 @default.
• W4318833445 cites W2085813532 @default.
• W4318833445 cites W2115770728 @default.
• W4318833445 cites W2122425165 @default.
• W4318833445 cites W2122824397 @default.
• W4318833445 cites W2127351305 @default.
• W4318833445 cites W2138711135 @default.
• W4318833445 cites W2156792824 @default.
• W4318833445 cites W2166251900 @default.
• W4318833445 cites W2204380132 @default.
• W4318833445 cites W2279957130 @default.
• W4318833445 cites W2397969748 @default.
• W4318833445 cites W2913784281 @default.
• W4318833445 cites W3000349607 @default.
• W4318833445 cites W3094663729 @default.
• W4318833445 cites W3204570395 @default.
• W4318833445 cites W3214790250 @default.
• W4318833445 cites W4220759019 @default.
• W4318833445 cites W4256315541 @default.
• W4318833445 cites W4281849329 @default.
• W4318833445 cites W4304166241 @default.
• W4318833445 cites W2031130059 @default.
• W4318833445 doi "https://doi.org/10.3390/molecules28031378" @default.
• W4318833445 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36771044" @default.
• W4318833445 hasPublicationYear "2023" @default.
• W4318833445 type Work @default.
• W4318833445 citedByCount "0" @default.
• W4318833445 crossrefType "journal-article" @default.
• W4318833445 hasAuthorship W4318833445A5003434108 @default.
• W4318833445 hasAuthorship W4318833445A5016805219 @default.
• W4318833445 hasAuthorship W4318833445A5026687725 @default.
• W4318833445 hasAuthorship W4318833445A5035499808 @default.
• W4318833445 hasAuthorship W4318833445A5037603558 @default.
• W4318833445 hasAuthorship W4318833445A5039743320 @default.
• W4318833445 hasAuthorship W4318833445A5040901130 @default.
• W4318833445 hasAuthorship W4318833445A5051858730 @default.
• W4318833445 hasAuthorship W4318833445A5068356184 @default.
• W4318833445 hasAuthorship W4318833445A5070902222 @default.
• W4318833445 hasAuthorship W4318833445A5080365151 @default.
• W4318833445 hasAuthorship W4318833445A5084808804 @default.
• W4318833445 hasBestOaLocation W43188334451 @default.
• W4318833445 hasConcept C109159458 @default.
• W4318833445 hasConcept C185592680 @default.
• W4318833445 hasConcept C203014093 @default.
• W4318833445 hasConcept C28328180 @default.
• W4318833445 hasConcept C71924100 @default.
• W4318833445 hasConcept C79904392 @default.
• W4318833445 hasConcept C86803240 @default.
• W4318833445 hasConcept C8891405 @default.
• W4318833445 hasConcept C95444343 @default.
• W4318833445 hasConcept C98274493 @default.
• W4318833445 hasConceptScore W4318833445C109159458 @default.
• W4318833445 hasConceptScore W4318833445C185592680 @default.
• W4318833445 hasConceptScore W4318833445C203014093 @default.
• W4318833445 hasConceptScore W4318833445C28328180 @default.
• W4318833445 hasConceptScore W4318833445C71924100 @default.
• W4318833445 hasConceptScore W4318833445C79904392 @default.
• W4318833445 hasConceptScore W4318833445C86803240 @default.
• W4318833445 hasConceptScore W4318833445C8891405 @default.
• W4318833445 hasConceptScore W4318833445C95444343 @default.
• W4318833445 hasConceptScore W4318833445C98274493 @default.
• W4318833445 hasIssue "3" @default.
• W4318833445 hasLocation W43188334451 @default.
• W4318833445 hasLocation W43188334452 @default.
• W4318833445 hasLocation W43188334453 @default.
• W4318833445 hasOpenAccess W4318833445 @default.
• W4318833445 hasPrimaryLocation W43188334451 @default.
• W4318833445 hasRelatedWork W2320344990 @default.
• W4318833445 hasRelatedWork W2322826964 @default.

• next